TSPYL4 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the TSPYL4 protein, a member of the Testis-Specific Y-like (TSPY) family of proteins. TSPYL4 is involved in a variety of cellular processes, including the regulation of cell cycle progression, gene expression, and protein stability. It is thought to act as a regulator of several important signaling pathways by influencing the activity of various transcription factors and proteins involved in cellular stress responses. TSPYL4 inhibitors function by binding to the protein, thereby preventing it from carrying out its regulatory roles. These inhibitors can interfere with TSPYL4's ability to modulate key proteins or disrupt its interactions with other cellular components, resulting in alterations to cellular homeostasis and signaling networks.
Chemically, TSPYL4 inhibitors are typically designed with high specificity for the TSPYL4 protein, targeting regions critical for its function, such as protein-protein interaction domains or areas responsible for binding DNA or other regulatory molecules. The structural design of these inhibitors often involves detailed studies of the three-dimensional conformation of TSPYL4 to ensure that they can effectively block its activity without affecting other related proteins in the TSPY family. Researchers are particularly interested in understanding how TSPYL4 inhibitors affect the broader regulatory roles of this protein, including its impact on cellular growth and gene expression patterns. By studying these inhibitors, scientists can gain deeper insights into the mechanisms by which TSPYL4 regulates cellular processes, contributing to a more comprehensive understanding of protein regulation and signaling pathways within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor. By altering DNA methylation patterns, RG108 can potentially modify TSPYL4-mediated chromatin remodeling. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
An inhibitor of the BET family of bromodomains. If TSPYL4 interacts with proteins possessing bromodomains, JQ1 can be an indirect modulator. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
An HDAC inhibitor that could modify the acetylation status of histones or other proteins TSPYL4 might interact with. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
Inhibitor of histone lysine methyltransferases EZH1/2. If TSPYL4 is involved in histone methylation processes, UNC1999 can be an influential agent. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Another HDAC inhibitor, affecting the acetylation status, potentially impacting TSPYL4's protein-protein interactions or functions. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Targets the EZH2 methyltransferase, potentially affecting histone methylation and any TSPYL4-related processes therein. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
Inhibits EZH2, impacting histone H3 methylation, potentially influencing TSPYL4's interactions or functions associated with histone methylation. | ||||||
PFI-1 | 1403764-72-6 | sc-478504 | 5 mg | $98.00 | ||
A BET bromodomain inhibitor, potentially affecting any TSPYL4 interactions with BET-associated proteins. | ||||||